BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simioni C, Ultimo S, Martelli AM, Zauli G, Milani D, McCubrey JA, Capitani S, Neri LM. Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia. Oncotarget 2016;7:79842-53. [PMID: 27821800 DOI: 10.18632/oncotarget.13035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zheng T, Yang J. Differential expression of EWI-2 in endometriosis, its functional role and underlying molecular mechanisms. J Obstet Gynaecol Res 2017;43:1180-8. [PMID: 28544021 DOI: 10.1111/jog.13333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 Tsaouli G, Ferretti E, Bellavia D, Vacca A, Felli MP. Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression. J Immunol Res 2019;2019:5601396. [PMID: 31346528 DOI: 10.1155/2019/5601396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang SS, Chen G, Li SH, Pang JS, Cai KT, Yan HB, Huang ZG, He RQ. Identification and validation of an individualized autophagy-clinical prognostic index in bladder cancer patients. Onco Targets Ther 2019;12:3695-712. [PMID: 31190871 DOI: 10.2147/OTT.S197676] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
4 Simioni C, Bergamini F, Ferioli M, Rimondi E, Caruso L, Neri LM. New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances. Hematol Oncol 2020;38:22-33. [PMID: 31487068 DOI: 10.1002/hon.2678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peterson JF, Pitel BA, Smoley SA, Smadbeck JB, Johnson SH, Vasmatzis G, Koon SJ, Webley MR, McGrath M, Bayerl MG, Baughn LB, Rowsey RA, Ketterling RP, Greipp PT, Hoppman NL. Detection of a cryptic NUP214/ABL1 gene fusion by mate-pair sequencing (MPseq) in a newly diagnosed case of pediatric T-lymphoblastic leukemia. Cold Spring Harb Mol Case Stud 2019;5:a003533. [PMID: 30936193 DOI: 10.1101/mcs.a003533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Singh P, Kumar V, Gupta SK, Kumari G, Verma M. Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review. Med Oncol 2021;38:10. [PMID: 33452624 DOI: 10.1007/s12032-021-01462-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Montaño A, Forero-Castro M, Marchena-Mendoza D, Benito R, Hernández-Rivas JM. New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update. Cancers (Basel) 2018;10:E110. [PMID: 29642462 DOI: 10.3390/cancers10040110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
8 Zhao Y, Yang L, He J, Yang H. STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinoma. Tumour Biol 2017;39:1010428317711644. [PMID: 28720063 DOI: 10.1177/1010428317711644] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
9 Huang FL, Yu SJ, Li CL. Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia. Cancer Control 2021;28:10732748211019138. [PMID: 34169775 DOI: 10.1177/10732748211019138] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kong D, Fan S, Sun L, Chen X, Zhao Y, Zhao L, Guo Z, Li Y. Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion. Hematol Oncol 2021;39:222-30. [PMID: 33300153 DOI: 10.1002/hon.2831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Simioni C, Martelli AM, Zauli G, Melloni E, Neri LM. Targeting mTOR in Acute Lymphoblastic Leukemia. Cells 2019;8:E190. [PMID: 30795552 DOI: 10.3390/cells8020190] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
12 Zhang XH, Wang XY, Zhou ZW, Bai H, Shi L, Yang YX, Zhou SF, Zhang XC. The combination of digoxin and GSK2606414 exerts synergistic anticancer activity against leukemia in vitro and in vivo. Biofactors 2017;43:812-20. [PMID: 28817203 DOI: 10.1002/biof.1380] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Kramer B, Polit M, Birk R, Rotter N, Aderhold C. HIF-1α and mTOR - Possible Novel Strategies of Targeted Therapies in p16-positive and -negative HNSCC. Cancer Genomics Proteomics 2018;15:175-84. [PMID: 29695399 DOI: 10.21873/cgp.20075] [Reference Citation Analysis]
14 Haider Z, Larsson P, Landfors M, Köhn L, Schmiegelow K, Flaegstad T, Kanerva J, Heyman M, Hultdin M, Degerman S. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression. Cancer Med 2019;8:311-24. [PMID: 30575306 DOI: 10.1002/cam4.1917] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
15 Zhang H, Yin SL, Wang LH, Jia LN, Su GY, Liu XQ, Zhou F, Breslin P, Meng R, Li QY, Yang JY, Wu CF. Seed oil of Brucea javanica induces apoptosis through the PI3K/Akt signaling pathway in acute lymphocytic leukemia Jurkat cells. Chin J Nat Med 2021;19:608-20. [PMID: 34419260 DOI: 10.1016/S1875-5364(21)60060-2] [Reference Citation Analysis]